Speciality Care is a focus on a specific area of medicine or a group of patients with specific types of symptoms and conditions.1 Speciality care providers and products focus on chronic (ongoing) conditions as well as acute (sudden) conditions. They also use a range of speciality medicines to treat both genetic disorders and metabolic disorders.
The area of speciality care deals with both chronic and acute conditions, genetic diseases, and genetic metabolic disorders. These might be related to immunology, haematology, cardiology, or dermatology. Medical care and treatments are divided into two distinct forms: primary and speciality care.2 Primary care includes general practice and is normally a person’s first point of contact with medical practitioners.
Our Speciality Care portfolio consists of products that treat genetic and metabolic diseases, as well as the symptoms of those conditions. The conditions below are categorised as requiring speciality care.
Sobi’s focus within Specialty Care
Hereditary Tyrosinaemia Type 1 (HT-1)
HT-1 is a condition where the body is unable to break down tyrosine, one of protein's essential building blocks. When the body cannot break down tyrosine, high levels build up in the blood and form a toxic substance known as succinylacetone.
Alkaptonuria (AKU)
Alkaptonuria (AKU) is also known as Black Bone Disease or Black Urine Disease due to the disease characteristics. It is an extremely rare genetic condition, which can cause significant damage to the bones, cartilage and tissue which eventually leads to joint disease.
Hereditary Transthyretin Amyloidosis (hATTR)
Hereditary transthyretin amyloidosis (hATTR) is a rare, progressive and debilitating genetic disease caused by a gene change or mutation in the transthyretin (TTR) protein. It is a type of amyloidosis, a group of four diseases with various causes and symptoms.
Familial Chylomicronemia Syndrome (FCS)
Familial Chylomicronaemia Syndrome (FCS) is an ultra-rare disease which causes extremely high levels of triglycerides in the blood, which are a type of fat that come from food.
Therapeutic areas
Learn more about all our therapeutic areas spanning - Immunology, Haematology and Specialty Care.
Development pipeline
We see innovation as essential to our vision of being a global leader in rare diseases. We invest in research and development to continue to provide innovative treatments.
References
1Centers for Medicare & Medicaid Services: Specialty Care
https://www.cms.gov/priorities/innovation/key-concepts/specialty-care
2NHS Providers: The NHS provider sector
https://nhsproviders.org/topics/delivery-and-performance/the-nhs-provider-sector